COVID-19 Pandemic Disrupts Delivery of Neonatal Seizure Developmental Services
Researchers sought to determine the impact of the COVID-19 pandemic on developmental service delivery among children with a history of neonatal seizures.
Pregnancy
COVID-19 Vaccination Safe During Pregnancy
Maternal vaccination with the Pfizer-BioNTech COVID-19 vaccine in pregnancy is safe and not associated with detrimental outcomes to the offspring.
Vaccination in Pregnancy Prevents COVID-19 Hospitalization in Infants
Maternal completion of a two-dose primary mRNA COVID-19 vaccination series during pregnancy is 61% effective for preventing COVID-19 hospitalization in infants.
Woman Cured of HIV After Umbilical Cord Blood Transplant
Cord blood contained a mutation that blocks HIV entry into cells and came from a partially matched donor
Antibodies Persist for Infants Born to COVID-19-Vaccinated Moms
A majority of infants born to COVID-19-vaccinated mothers have persistent anti-spike (anti-S) antibodies at six months.
Risk for Maternal Morbidity, Death Increased With SARS-CoV-2 Infection
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is associated with an increased risk for serious maternal morbidity or mortality.
Extensive Placental Damage Identified in COVID-19-Linked Stillbirths
Mechanism of stillbirth, neonatal death is hypoxic-ischemic injury resulting from placental destruction and insufficiency caused by SARS-CoV-2
Is In-Utero Exposure to COVID-19 Tied With Infant Neurodevelopmental Status?
Researchers sought to examine the associations between maternal SARS-CoV-2 infection during pregnancy, being born during the COVID-19 pandemic regardless of in utero COVID-19 exposure, and neurodevelopmental status at 6 months.
Immunogenicity of PCV-10 Vaccination in HIV-Exposed Infants
Researchers compared the immunogenicity of the pneumococcal 10-valent conjugate vaccine (PCV-10) among HIV-exposed uninfected infants born to mothers who received PCV-10, PPV-23, or placebo during pregnancy.
The Seventh Update of the WHO’s Living Guideline on COVID-19 Therapeutics
The World Health Organization assess the use of Janus kinase inhibitors and monoclonal antibodies in the seventh update of their living guideline on COVID-19 therapeutics.
- Loading...
Loading...
Loading... 
Loading...